ArticleFrontiers in network physiology2026
Metabolomic signatures associated with muscle dysfunction during the SIRIUS-21 space analog mission.
Article in Frontiers in network physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There is growing interest in exploring outer space to expand scientific knowledge and access valuable material resources. However, progress is limited by the harsh space environment, including microgravity, ionizing radiation, isolation and confinement (IC), disrupted circadian rhythms, and nutritional challenges. These stressors contribute to health problems across multiple organ systems, particularly the musculoskeletal, immune, renal/urinary, and cardiovascular systems. Although we have extensive insight into skeletal muscle pathophysiological changes induced by these spaceflight-related stressors, the molecular mechanisms underlying functional alterations caused by prolonged IC in skeletal muscle remain incompletely understood. Methods: During the 8-month SIRIUS-21 space analog mission, five participants (3 males, 2 females) underwent plasma and saliva sampling and electromyography (EMG) assessment at five time points: baseline (Ingress), early, mid, and late isolation and confinement (IC), and 14 days post-mission (Egress). Metabolites were analyzed by LC-MS/MS. Longitudinal metabolite changes were assessed using repeated-measures ANOVA with Tukey HSD Results: Metabolomic profiling identified 45 skeletal muscle-related metabolites with nominally significant longitudinal changes (p < 0.0001-0.05): 8 were detected in both plasma and saliva, 26 only in plasma, and 11 only in saliva. Direct exploratory Spearman correlations with EMG metrics were identified for a subset of metabolites, including pipecolic acid, phenylacetic acid, L-phenylalanine, L-acetylcarnitine, L-glutamine, and pyruvaldehyde. EMG findings showed a progressive decline in muscle activation and fatigue resistance during prolonged IC, with partial recovery after egress. Exploratory sex-related analyses were interpreted descriptively because the cohort included only two females and three males. Conclusion: Prolonged IC was accompanied by coordinated changes in muscle function and circulating or salivary metabolites. The identified metabolites represent candidate metabolic signatures associated with muscle dysfunction and require validation in larger independent cohorts before diagnostic or therapeutic utility can be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.